Literature DB >> 31539124

MiR-99a suppresses cell migration and invasion by regulating IGF1R in gastric cancer.

X-L Xu1, A-X Guo, Q-Y Pan, A-L Chang, C-R Zhao.   

Abstract

OBJECTIVE: Gastric cancer is a common kind of gastrointestinal malignancies. Increasing evidence indicates dysregulation of microRNA-99a (miR-99a) in gastric cancer, and has been extensively investigated in terms of cancer formation, progression, diagnosis, therapy, and prognosis. The purpose of this study is to explore how miR-99a worked in gastric cancer on migration and invasion. PATIENTS AND METHODS: The mRNA and protein levels of miR-99a and insulin-like growth factor 1 receptor (IGF1R) in gastric cancer were measured by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) and Western blot. Transwell assay was employed to analyze the migratory and invasive capacities. The Dual-Luciferase reporter assay was performed to confirm miR-99a mediated the expression of IGF1R by directly targeting its mRNA 3'-untranslated regions (3'-UTR) in gastric cancer cells.
RESULTS: MiR-99a was discovered to be significantly downregulated while IGF1R was upregulated in gastric cancer tissues and cell lines. The expression of miR-99a had a negative correlation with the IGF1R expression in gastric cancer tissues. Moreover, miR-99a was low expressed in gastric cancer cells HGC-27 and MGC-803 compared to the normal cell line. MiR-99a suppressed the migration and invasion through directly binding to the 3'-UTR of IGF1R mRNA in HGC-27 cells. In addition, IGF1R could reverse partial roles of miR-99a on migration and invasion in gastric cancer.
CONCLUSIONS: MiR-99a inhibited the migratory and invasive abilities by regulating the expression of IGF1R. MiR-99a was downregulated while IGF1R was upregulated in gastric cancer cell lines. The newly identified miR-99a/IGF1R axis provides novel insight into the pathogenesis of gastric cancer.

Entities:  

Year:  2019        PMID: 31539124     DOI: 10.26355/eurrev_201909_18845

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  6 in total

1.  CircATP5SL promotes infantile haemangiomas progression via IGF1R regulation by targeting miR-873-5p.

Authors:  Zhiqiang Wei; Xiaoqi Yuan; Qi Ding; Yanan Xu; Lu Hong; Jianhua Wang
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

2.  miR-335-5p suppresses gastric cancer progression by targeting MAPK10.

Authors:  Yi Gao; Yanfeng Wang; Xiaofei Wang; Changan Zhao; Fenghui Wang; Juan Du; Huahua Zhang; Haiyan Shi; Yun Feng; Dan Li; Jing Yan; Yan Yao; Weihong Hu; Ruxin Ding; Mengjie Zhang; Lumin Wang; Chen Huang; Jing Zhang
Journal:  Cancer Cell Int       Date:  2021-01-22       Impact factor: 5.722

3.  HS3ST2 and Its Related Molecules as Potential Biomarkers for Predicting Lymph Node Metastasis in Patients with Colorectal Cancer.

Authors:  Guangyu Gao; Jiaofeng Shen; Xinya Shi
Journal:  Onco Targets Ther       Date:  2021-06-25       Impact factor: 4.345

4.  MicroRNA (miR) dysregulation during Helicobacter pylori-induced gastric inflammation and cancer development: critical importance of miR-155.

Authors:  Christian Prinz; David Weber
Journal:  Oncotarget       Date:  2020-03-10

5.  Identification of the miRNA signature and key genes in colorectal cancer lymph node metastasis.

Authors:  Xi Wang; Guangyu Gao; Zhengrong Chen; Zhihao Chen; Mingxiao Han; Xiaolu Xie; Qiyuan Jin; Hong Du; Zhifei Cao; Haifang Zhang
Journal:  Cancer Cell Int       Date:  2021-07-07       Impact factor: 5.722

Review 6.  Vitamin D modulation and microRNAs in gastric cancer: prognostic and therapeutic role.

Authors:  Elena Gallardo Martin; Antia Cousillas Castiñeiras
Journal:  Transl Cancer Res       Date:  2021-06       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.